Honnorat J, Plazat LO. Autoimmune encephalitis and psychiatric disorders. Rev Neurol (Paris). 2018;174(4):228–36.

Article  CAS  PubMed  Google Scholar 

Bost C, Pascual O, Honnorat J. Autoimmune encephalitis in psychiatric institutions: current perspectives. Neuropsychiatr Dis Treat. 2016;12:2775–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tebartz van Elst L, Bechter K, Prüss H, Hasan A, Steiner JH, Leypoldt F, et al. Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment. Nervenarzt. 2019;90(7):745–61.

Article  PubMed  Google Scholar 

Endres D, Maier V, Leypoldt F, Wandinger KP, Lennox B, Pollak TA, et al. Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases. Psychol Med. 2020;52(6):1–12.

Google Scholar 

Hansen N, Lüdecke D, Maier HB, Steiner J, Neyazi AN. Psychiatrische Autoimmunenzephalitis – Diagnose und therapeutische Ansätze. psychu2d. 2023;17(01):13–28.

Google Scholar 

Pollak TA, Lennox BR, Müller S, Benros ME, Prüss H, Tebartz van Elst L, et al. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry. 2020;7(1):93–108.

Article  PubMed  Google Scholar 

Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391–404.

Article  PubMed  PubMed Central  Google Scholar 

Pollak TA, McCormack R, Peakman M, Nicholson TR, David AS. Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychol Med. 2014;44(12):2475–87.

Article  CAS  PubMed  Google Scholar 

Chen CH, Cheng MC, Liu CM, Liu CC, Lin KH, Hwu HG. Seroprevalence survey of selective anti-neuronal autoantibodies in patients with first-episode schizophrenia and chronic schizophrenia. Schizophr Res. 2017;190:28–31.

Article  PubMed  Google Scholar 

Sæther SG, Schou M, Kondziella D. What is the significance of onconeural antibodies for psychiatric symptomatology? A systematic review. BMC Psychiatry. 2017;17(1):161.

Article  PubMed  PubMed Central  Google Scholar 

Colijn MA, Ismail Z. Clinically relevant anti-neuronal cell surface antibodies in schizophrenia spectrum Disorders. Neuropsychobiology. 2019;78(2):70–8.

Article  CAS  PubMed  Google Scholar 

Blackman G, Lim MF, Pollak T, Al-Diwani A, Symmonds M, Mazumder A, et al. The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data. J Neurol. 2022;269(10):5302–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asgari S, Gashirai M, Smith J, Alusi S. Seronegative autoimmune limbic encephalitis with psychiatric symptoms. Prog Neurol Psychiatry. 2022;26(1):14–7.

Article  Google Scholar 

The ICD-10 classification of mental and behavioural disorders [Internet]. 2019. https://icd.who.int/browse10/2019/en. Accessed 8 Nov 2023.

Guasp M, Giné-Servén E, Maudes E, Rosa-Justicia M, Martínez-Hernández E, Boix-Quintana E, et al. Clinical, neuroimmunologic, and CSF investigations in first episode psychosis. Neurology. 2021;97(1):e61–75.

Article  PubMed  Google Scholar 

Graus F, Dalmau J. Autoimmune encephalitis or autoimmune psychosis? Eur Neuropsychopharmacol. 2021;50:112–4.

Article  CAS  PubMed  Google Scholar 

Wang J, Liu X, Lian J, Zheng H, Cai D, Cai H, et al. Autoimmune antibodies in first-episode psychosis with red flags: a hospital-based case-control study protocol. Front Psychiatry. 2022;13:976159.

Article  PubMed  PubMed Central  Google Scholar 

Guasp M, Dalmau J. Searching for neuronal antibodies in psychiatric diseases: uncertain findings and implications. Neurology. 2023;101(15):656–60.

Article  CAS  PubMed  Google Scholar 

Dalmau J, Guasp M, Graus F. Author response: clinical, neuroimmunologic, and CSF investigations in first episode psychosis. Neurology. 2021;97(21):1010.

Article  PubMed  Google Scholar 

Endres D, Lüngen E, Hasan A, Kluge M, Fröhlich S, Lewerenz J, et al. Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany. Mol Psychiatry. 2022;27(3):1479–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Araújo MV, Monteiro RB, Samões R, Norton A, Correia AP. Persistently positive anti-NMDA receptor antibodies in chronic psychotic disorder: foe or innocent bystander? Psychiatry Clin Neurosci. 2021;75(8):269–70.

Article  PubMed  Google Scholar 

Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis. JAMA Neurol. 2013;70(9):1133–9.

Article  PubMed  Google Scholar 

Endres D, Matysik M, Feige B, Venhoff N, Schweizer T, Michel M, et al. Diagnosing organic causes of schizophrenia spectrum disorders: findings from a one-year cohort of the Freiburg Diagnostic Protocol in Psychosis (FDPP). Diagnostics. 2020;10(9):691.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Doss S, Wandinger K-P, Hyman BT, Panzer JA, Synofzik M, Dickerson B, et al. High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types. Ann Clin Transl Neurol. 2014;1(10):822–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giannoccaro MP, Gastaldi M, Rizzo G, Jacobson L, Vacchiano V, Perini G, et al. Antibodies to neuronal surface antigens in patients with a clinical diagnosis of neurodegenerative disorder. Brain Behav Immun. 2021;96:106–12.

Article  CAS  PubMed  Google Scholar